US 10933042
Intravenous baclofen formulations and treatment methods
granted A61KA61K31/197A61K45/06
Quick answer
US patent 10933042 (Intravenous baclofen formulations and treatment methods) held by Regents of the University of Minnesota expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/197, A61K45/06, A61K9/0019, A61P